Our ground checks suggest improving business sentiment following Purbaya’s appointment, as his pro-growth and consultative stance has begun to restore optimism. Macro indicators point to firmer momentum toward the year-end, supported by typical seasonality and more accommodative fiscal measures that should reinforce consumption-led growth. We re-iterate our tactical allocation to big-cap laggards and consumer names. Top picks: JPFA, CMRY and AMRT. Highlights • Our ground check suggests that bus...
Sector Update | Consumer Our ground checks suggest improving business sentiment following Purbaya’s appointment, as his pro-growth and consultative stance has begun to restore optimism. Macro indicators point to firmer momentum toward the year-end, supported by typical seasonality and more accommodative fiscal measures that should reinforce consumption-led growth. We re-iterate our tactical allocation to big-cap laggards and consumer names. Top picks: JPFA, CMRY and AMRT. Company Results | Bank...
Most 3Q25 results are expected to be in line, except for ACES, which may fall short due to heightened competition. JPFA is likely to stand out, supported by higher broiler prices and continued cost efficiency. The recent proposed VAT reduction by the government provides positive sentiment. Our channel checks indicate improving consumer confidence, supported by recent pro-growth policies, with sentiment turning more constructive towards year-end. Top picks: JPFA, AMRT, and CMRY. Highlights • Mos...
Economics | Indonesia's External Debt Growth Cools As Borrowing Eases In Aug 25, Indonesia's external debt growth slowed significantly to 1.97% yoy, despite a slight monthly increase to US$431.9b. This deceleration was driven by declining public sector debt and a private sector contraction, improving key debt ratios. Looking ahead, debt growth is expected to accelerate with increased domestic spending, but will face challenges from a strong US dollar and high global bond yields, posing risks to ...
Indonesia’s 10-year government bond yield has fallen to 6.3% and could ease further to 6.1% by end-25, narrowing the yield gap with equities. Around 19 JCI stocks offer dividend yields above bond yields, led by SOE banks (>8%) and selected consumers and commodities (filtered by decent liquidity). However, we think HMSP and UNVR are dividend traps, while cyclical resource dividend yields carry risks and rewards that highly depend on the commodity price cycle. Top dividend picks: BBNI and AKRA.
GREATER CHINA Update Baoshan Iron & Steel (600019 CH/BUY/Rmb7.44/Target: Rmb8.20) Riding the policy wave, watching for undercurrents. Shenzhen Mindray Bio-Medical Electronics (300760 CH/BUY/Rmb231.84/Target: Rmb325.00) Regaining growth momentum from Q3 2025, on track for top 10 global medtech status. INDONESIA Sector Consumer 2Q25 preview: Mixed results. Results Bank Negara Indonesia (BBNI IJ/BUY/Rp4,090/Target: Rp5,...
Despite macroeconomic headwinds, we expect 1H25 results across the consumer sector to reflect resilient momentum in selective segments, with performance diverging by product category, pricing power, margin management and adaptability. While weak purchasing power likely weighed on mass-market demand, easing soft commodity prices may improve sentiment. We upgrade the sector to OVERWEIGHT. Top picks: KLBF, CMRY and ERAA.
Consumer: 2Q25 preview: Mixed results. Bank Negara Indonesia (BBNI IJ/BUY/Rp4,090/Target: Rp5,100): 2Q25: NIM likely to have bottomed, with recovery expected in 2H25. TRADERS’ CORNER Tower Bersama Infrastructure (TBIG IJ): Technical BUY Indofood CBP Sukses Makmur (ICBP IJ): Technical BUY
ACES posted a sharp SSSG decline of 14.1% in Apr 25, driven by softer consumer spending and the calendar shift in Ramadan timing. 4M25 SSSG decelerated to -2.3% (3M25: +2.2%). Despite weak monthly sales, 4M25 indicative sales grew 4.2% yoy, supported by five newly-opened stores in 4M25. We maintain BUY with an unchanged target price of Rp565 due to ACES’ undemanding valuation of 9.3x 2025F PE and a dividend yield of 6.0-7.0%.
GREATER CHINA Results Baidu Inc (9888 HK/HOLD/HK$86.10/Target: HK$91.00) 1Q25: Solid earnings beat, fuelled by AI cloud growth and monetisation visibility. XPeng Inc (9868 HK/BUY/HK$77.55/Target: HK$150.00) 1Q25: Results beat expectations. Maintain BUY with a target price of HK$150.00. INDONESIA Strategy Indonesia’s State Budget Position As Of Apr 25 Surplus returns, mom improvement in revenue collections, spen...
Strategy: Indonesia’s State Budget Position As Of Apr 25: Surplus returns, mom improvement in revenue collections, spending focused on regional transfers and non-K/L spending. Aspirasi Hidup Indonesia (ACES IJ/BUY/Rp525/Target: Rp565): SSSG down in April; growth backed by expansion and cost normalisation. TRADERS’ CORNER AKR Corporindo (AKRA IJ): Technical BUY Bumi Serpong Damai (BSDE IJ): Technical BUY
GREATER CHINA Sector Property Supportive policy remarks by Premier Li Qiang point to further upside; upcoming Politburo meeting to be an important policy window. Results Fuyao Glass Industry Group (3606 HK/BUY/HK$49.15/Target: HK$68.00) 1Q25: Earnings up 46% yoy, in line with estimates. Maintain BUY. Target price: HK$68.00. Han’s Laser (002008 CH/BUY/Rmb24.27/Target: Rmb32.20) 1Q25: Net pro...
ACES posted improved SSSG of 8.6% in Mar 25 vs -6.6% in Feb 25. However, we cut our 2025 sales and net profit estimates by 5% and 20% respectively as we lower our SSSG assumption to 1% (previously: 7%) and raise our promotion expenses by 150bp, following management’s guidance. With the new assumptions, we now expect a 1.6% net profit growth in 2025. We believe the weak growth has been priced in, as ACES is currently trading at 8.3x 2025F PE. Maintain BUY with a lower target price of Rp565.
Donald Trump announced a 25% tariff on imports from Mexico and Canada. Imports of oil from Canada into the US are subject to a 10% tariff, in addition to an extra 10% tariff on imports from the US, Canada retaliated by imposing a 25% tariff on imports from the US, including beverages, cosmetics and paper products worth US$20b. Mexico and China are also expected to retaliate. The biggest risk is the potential underperformance of the JCI. Our top picks are ASII, BMRI, BBNI, BBTN, CMRY, KLBF, SIDO,...
Strategy: Trade War Begins: Our top picks are ASII, BMRI, BBNI, BBTN, CMRY, KLBF, SIDO, CTRA, ACES and GOTO. We have an end-25 target of 8,200 for the JCI. TRADERS’ CORNER Ciputra Development (CTRA IJ): Technical BUY Indo Tambangraya Megah (ITMG IJ): Technical BUY
The JCI delivered a 3.7% decline in 2024, underperforming the MSASJ after two previous years of outperformance. IDXENER was the top performing sector in the JCI with a 31.9% return. IDXFIN dropped 6.2% in 2024 with big banks delivering negative returns. Gains of over 100% have been observed in MLPT, SRAJ, JSPT, PTRO, PANI, CLEO and BRMS. The worst performers are SMGR, UNVR, MDKA, GGRM, TOWR, TLKM and HMSP. For 2025, our top picks are ASII, BMRI, BBNI, BRIS, CMRY, KLBF, SMRA, ACES and GOTO.
Strategy: 2024 JCI Return Analysis: Our top picks are ASII, BMRI, BBNI, BRIS, CMRY, KLBF, SMRA, ACES and GOTO. We have an end-25 target of 8,200 for the JCI. TRADERS’ CORNER Telkom Indonesia (TLKM IJ): Technical BUY Trimegah Bangun Persada (NCKL IJ): Technical BUY
MDIY will list at the offering price of Rp1,650/share. This translates to a market capitalisation of US$2.9b. Margins at MDIY are higher and MDIY has earned more than 40% ROE over the past two years compared with ACES’ ROE of 15%. MDIY’s offering price translates to a 39x 2024 annualised PE compared with ACES’ 15x 2024F PE. Based on valuation, we prefer ACES. Maintain BUY. Target price: Rp1,200.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.